Literature DB >> 20697327

Quantitative assessment of β-cell apoptosis and cell composition of isolated, undisrupted human islets by laser scanning cytometry.

Ivan Todorov1, Indu Nair, Alina Avakian-Mansoorian, Jeffrey Rawson, Keiko Omori, Taihei Ito, Luis Valiente, Itzia Iglesias-Meza, Chris Orr, Keh-Dong Shiang, Kevin Ferreri, Ismail H Al-Abdullah, Yoko Mullen, Fouad Kandeel.   

Abstract

BACKGROUND: Assays for assessing human islet cell quality, which provide results before transplantation, would be beneficial to improve the outcomes for islet transplantation therapy. Parameters such as percent β-cell apoptosis and cell composition are found to vary markedly between different islet preparations and may serve as markers of islet quality. We have developed fluorescence-based assays using laser scanning cytometry for assessing β-cell apoptosis and islet cell composition on serial sections of intact isolated islets.
METHODS: Isolated human islets were fixed in formalin and embedded in paraffin. Serial sections were immunostained for the pancreatic hormones and acinar and ductal cell markers. DNA fragmentation was used to label apoptotic cells. Stained cells were quantified using an iCys laser scanning cytometer.
RESULTS: Islet preparations from 102 human pancreatic islet isolations were analyzed. For the whole set of islet preparations, we found a mean islet cell composition of 54.5%±1.2% insulin-positive, 33.9%±1.2% glucagon, 12.1%±0.7% somatostatin, and 1.5%±0.2% pancreatic polypeptide-positive cells. The apoptotic β cells were 2.85%±0.4% with a range of 0.27% to 18.3%. The percentage of apoptotic β cells correlated well (P<0.0001, n=59) with results obtained in vivo by transplantation of the corresponding islets in diabetic NODscid mice.
CONCLUSIONS: The analysis of whole, nondissociated islets for cell composition and β-cell apoptosis using laser scanning cytometry gives reliable and reproducible results and could be performed both before islet transplantation and on preserved cell blocks at any time in future. Thus, they can be a powerful tool for islet quality assessment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20697327      PMCID: PMC2959131          DOI: 10.1097/TP.0b013e3181f1db5d

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  30 in total

1.  Early assessment of apoptosis in isolated islets of Langerhans.

Authors:  P Cattan; T Berney; S Schena; R D Molano; A Pileggi; C Vizzardelli; C Ricordi; L Inverardi
Journal:  Transplant Proc       Date:  2001 Feb-Mar       Impact factor: 1.066

2.  The use of laser scanning cytometry to assess depth of penetration of adenovirus p53 gene therapy in human xenograft biopsies.

Authors:  M J Grace; L Xie; M L Musco; S Cui; M Gurnani; R DiGiacomo; A Chang; S Indelicato; J Syed; R Johnson; L L Nielsen
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

3.  Automated, high-throughput assays for evaluation of human pancreatic islet function.

Authors:  Over Cabrera; M Caroline Jacques-Silva; Dora M Berman; Alberto Fachado; Felipe Echeverri; Ramon Poo; Aisha Khan; Norma S Kenyon; Camillo Ricordi; Per-Olof Berggren; Alejandro Caicedo
Journal:  Cell Transplant       Date:  2008       Impact factor: 4.064

Review 4.  Quality control for clinical islet transplantation: organ procurement and preservation, the islet processing facility, isolation, and potency tests.

Authors:  Toshiyuki Yamamoto; Akihiko Horiguchi; Masahiro Ito; Hideo Nagata; Hirohito Ichii; Camillo Ricordi; Shuichi Miyakawa
Journal:  J Hepatobiliary Pancreat Surg       Date:  2009-02-26

5.  Automated method for isolation of human pancreatic islets.

Authors:  C Ricordi; P E Lacy; E H Finke; B J Olack; D W Scharp
Journal:  Diabetes       Date:  1988-04       Impact factor: 9.461

6.  Microassay for glucose-induced preproinsulin mRNA expression to assess islet functional potency for islet transplantation.

Authors:  Keiko Omori; Masato Mitsuhashi; Ivan Todorov; Jeffrey Rawson; Keh-Dong Shiang; Fouad Kandeel; Yoko Mullen
Journal:  Transplantation       Date:  2010-01-27       Impact factor: 4.939

7.  2008 Update from the Collaborative Islet Transplant Registry.

Authors:  Rodolfo Alejandro; Franca B Barton; Bernhard J Hering; Steve Wease
Journal:  Transplantation       Date:  2008-12-27       Impact factor: 4.939

8.  Comprehensive analysis of human pancreatic islets using flow and laser scanning cytometry.

Authors:  I Iglesias; K Bentsi-Barnes; C Umeadi; L Brown; F Kandeel; I H Al-Abdullah
Journal:  Transplant Proc       Date:  2008-03       Impact factor: 1.066

9.  Characterization of pancreatic ductal cells in human islet preparations.

Authors:  Hirohito Ichii; Atsushi Miki; Toshiyuki Yamamoto; Ruth D Molano; Scott Barker; Atsuyoshi Mita; Rayner Rodriguez-Diaz; Dagmar Klein; Ricardo Pastori; Rodolfo Alejandro; Luca Inverardi; Antonello Pileggi; Camillo Ricordi
Journal:  Lab Invest       Date:  2008-09-08       Impact factor: 5.662

Review 10.  The clinical impact of islet transplantation.

Authors:  P Fiorina; A M J Shapiro; C Ricordi; A Secchi
Journal:  Am J Transplant       Date:  2008-10       Impact factor: 8.086

View more
  11 in total

Review 1.  Beta cell dynamics: beta cell replenishment, beta cell compensation and diabetes.

Authors:  Marlon E Cerf
Journal:  Endocrine       Date:  2013-03-13       Impact factor: 3.633

2.  mRNA of the pro-apoptotic gene BBC3 serves as a molecular marker for TNF-α-induced islet damage in humans.

Authors:  K Omori; M Mitsuhashi; K Ishiyama; I Nair; J Rawson; I Todorov; F Kandeel; Y Mullen
Journal:  Diabetologia       Date:  2011-05-13       Impact factor: 10.122

Review 3.  Laser scanning cytometry: principles and applications-an update.

Authors:  Piotr Pozarowski; Elena Holden; Zbigniew Darzynkiewicz
Journal:  Methods Mol Biol       Date:  2013

4.  Inflammatory biomarkers in the blood and pancreatic tissue of organ donors that predict human islet isolation success and function.

Authors:  Alina R Oancea; Keiko Omori; Chris Orr; Jeffrey Rawson; Donald C Dafoe; Ismail H Al-Abdullah; Fouad Kandeel; Yoko Mullen
Journal:  Islets       Date:  2020-01-14       Impact factor: 2.694

Review 5.  Engineering islets from stem cells for advanced therapies of diabetes.

Authors:  Johanna Siehler; Anna Karolina Blöchinger; Matthias Meier; Heiko Lickert
Journal:  Nat Rev Drug Discov       Date:  2021-08-10       Impact factor: 84.694

6.  International workshop: islet transplantation without borders enabling islet transplantation in Greece with international collaboration and innovative technology.

Authors:  Klearchos K Papas; Theodore Karatzas; Thierry Berney; Thomas Minor; Paris Pappas; François Pattou; James Shaw; Christian Toso; Henk-Jan Schuurman
Journal:  Clin Transplant       Date:  2013-01-18       Impact factor: 2.863

7.  (64)Cu labeled sarcophagine exendin-4 for microPET imaging of glucagon like peptide-1 receptor expression.

Authors:  Zhanhong Wu; Shuanglong Liu; Indu Nair; Keiko Omori; Stephen Scott; Ivan Todorov; John E Shively; Peter S Conti; Zibo Li; Fouad Kandeel
Journal:  Theranostics       Date:  2014-05-24       Impact factor: 11.556

Review 8.  Building Biomimetic Potency Tests for Islet Transplantation.

Authors:  Aaron L Glieberman; Benjamin D Pope; Douglas A Melton; Kevin Kit Parker
Journal:  Diabetes       Date:  2021-02       Impact factor: 9.461

9.  Gene expression signature predicts human islet integrity and transplant functionality in diabetic mice.

Authors:  Sunil M Kurian; Kevin Ferreri; Chia-Hao Wang; Ivan Todorov; Ismail H Al-Abdullah; Jeffrey Rawson; Yoko Mullen; Daniel R Salomon; Fouad Kandeel
Journal:  PLoS One       Date:  2017-10-02       Impact factor: 3.240

10.  Divergent antioxidant capacity of human islet cell subsets: A potential cause of beta-cell vulnerability in diabetes and islet transplantation.

Authors:  Atsushi Miki; Camillo Ricordi; Yasunaru Sakuma; Toshiyuki Yamamoto; Ryosuke Misawa; Atsuyoshi Mita; Ruth D Molano; Nosratola D Vaziri; Antonello Pileggi; Hirohito Ichii
Journal:  PLoS One       Date:  2018-05-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.